Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) Return on Assets (2021 - 2025)

Historic Return on Assets for Burning Rock Biotech (BNR) over the last 5 years, with Q3 2025 value amounting to 0.13%.

  • Burning Rock Biotech's Return on Assets rose 2900.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year increase of 2900.0%. This contributed to the annual value of 0.34% for FY2024, which is 1400.0% up from last year.
  • Burning Rock Biotech's Return on Assets amounted to 0.13% in Q3 2025, which was up 2900.0% from 0.15% recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's Return on Assets ranged from a high of 0.13% in Q3 2025 and a low of 0.61% during Q4 2022
  • For the 5-year period, Burning Rock Biotech's Return on Assets averaged around 0.4%, with its median value being 0.42% (2024).
  • Per our database at Business Quant, Burning Rock Biotech's Return on Assets tumbled by -3700bps in 2022 and then skyrocketed by 4100bps in 2025.
  • Burning Rock Biotech's Return on Assets (Quarter) stood at 0.24% in 2021, then crashed by -155bps to 0.61% in 2022, then grew by 2bps to 0.6% in 2023, then skyrocketed by 41bps to 0.35% in 2024, then skyrocketed by 63bps to 0.13% in 2025.
  • Its Return on Assets stands at 0.13% for Q3 2025, versus 0.15% for Q2 2025 and 0.26% for Q1 2025.